Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Biochemical Engineering >  Chinese Herbs >  FUMONISIN B1

FUMONISIN B1

Basic information Safety Supplier Related

FUMONISIN B1 Basic information

Product Name:
FUMONISIN B1
Synonyms:
  • MACROFUSINE
  • FUMONISIN B1
  • FUMONISIN B1, FUSARIUM MONILIFORME
  • FB1
  • 1,2,3-PROPANETRICARBOXYLIC ACID 1,1'-[1-(12-AMINO-4,9,11-TRIHYDROXY-2-METHYLTRIDECYL)-2-(1-METHYLPENTYL)-1,2-ETHANEDIYL] ESTER
  • 1,2,3-PROPANETRICARBOXYLIC ACID 1,1'-[12-AMINO-4,9,11-TRIHYDROXY-2-METHYLTRIDECYL)-2-(1-METHYLPENTYL)-1,2-ETHANEDIYL]ESTER
  • 1,2,3-propanetricarboxylicacid,1,1’-(1-(12-amino-4,9,11-trihydroxy-2-methyltr
  • Standard Solution Fumonisin B1
CAS:
116355-83-0
MF:
C34H59NO15
MW:
721.83
EINECS:
621-436-3
Product Categories:
  • antibiotic
  • Miscellaneous Natural Products
  • Amines
  • Chiral Reagents
  • Intermediates & Fine Chemicals
  • Pharmaceuticals
Mol File:
116355-83-0.mol
More
Less

FUMONISIN B1 Chemical Properties

Melting point:
>60oC
Boiling point:
713.81°C (rough estimate)
Density 
1.2207 (rough estimate)
refractive index 
1.6630 (estimate)
Flash point:
6 °C
storage temp. 
2-8°C
solubility 
Soluble in Water (up to 25 mg/ml).
form 
Powder
pka
3?+-.0.23(Predicted)
color 
White to tan
Stability:
Stable for 2 years from date of purchase as supplied. Solutions in distilled water may be stored at -20° for up to 3 months.
CAS DataBase Reference
116355-83-0
IARC
2B (Vol. 56) 1993, 2B (Vol. 82) 2002
More
Less

Safety Information

Hazard Codes 
Xn,T,F
Risk Statements 
40-36-20/21/22-11
Safety Statements 
36/37-16-26-45
RIDADR 
3172
WGK Germany 
3
RTECS 
TZ8350000
HazardClass 
6.1(b)
PackingGroup 
III
HS Code 
29221990
Hazardous Substances Data
116355-83-0(Hazardous Substances Data)

MSDS

More
Less

FUMONISIN B1 Usage And Synthesis

Description

Fumonisin B1 (116355-83-0) inhibits ceramide synthesis (sphinganine N-acyltransferase), IC50 = 100 nM. Inhibits de novo sphingolipid biosynthesis (IC50 = 0.7 μM) thereby blocking glycosphingolipid production.

Chemical Properties

white to tan powder

Uses

A mycotoxin produced by mold associated with corn. Fungal metabolite believed to cause leukoencephalomalacia in horses.

Uses

A serine/threonine phosphatase inhibitor.

Uses

Fumonisin B1 is a major analogue of a family of potent mycotoxins produced by various Fusarium species, associated with animal toxicity worldwide. In vitro, fumonisin B1 inhibits sphingosine N-acyl-transferase (ceramide synthase) and blocks the growth of axons.

Definition

ChEBI: Fumonisin B1 is a diester that results from the condensation of the 1-carboxy groups of two molecules of propane-1,2,3-tricarboxylic acid with hydroxy groups at positions 14 and 15 of (2S,3S,5R,10R,12S,14S,15R,16R)-2-amino-12,16-dimethylicosane-3,5,10,14,15-pentol. It has a role as a metabolite and a carcinogenic agent. It is a fumonisin, a primary amino compound, a diester and a triol. It is functionally related to a (2S,3S,5R,10R,12S,14S,15R,16R)-2-amino-12,16-dimethylicosane-3,5,10,14,15-pentol. It is a conjugate acid of a fumonisin B1(3-).

General Description

Fumonisin B1 is a neurotoxin and a phytotoxin. A cell-permeable mycotoxin that inhibits sphingolipid biosynthesis in rat kidney and in liver microsomes by inhibition of sphingosine N-acyltransferase (ceramide synthase) (IC50 = 100 nM). Cellular effects also appear to be induced by micromolar levels of FB1. Because it inhibits ceramide synthase activity, it elevates cellular levels of sphingoid bases, including sphinganine, resulting in overall inhibition of sphingolipid biosynthesis. Preferentially inhibits sphingomyelin biosynthesis in neuronal cells. Has carcinogenic properties.

Biological Activity

Mycotoxin produced by Fusarium moniliforme . Potently inhibits sphingosine N-acyltransferase (ceramide synthase), causing an accumulation of sphingoid bases (IC 50 ~ 75 nM). Also inhibits protein phosphatases; IC 50 values are 80, 300, 400, 500 and 3000 μ M for PP5, PP2C α , PP2A, PP1 γ 2 and PP2B respectively.

Biochem/physiol Actions

Fumonisin B1 acts as a hepatocarcinogen and causes hepatotoxicity in rats. In horses, it causes leukoencephalitis, and in pigs, it causes pulmonary edema syndrome. In China and southern parts of Africa, it is linked with high incidence of esophageal cancer in humans. It acts as an inhibitor of sphingosine N-acyltransferase enzyme (ceramide synthase), related to structural similarities between fumonisin B1 and sphingoid bases like sphingosine.

storage

Store at +4°C

References

1) Merrill et al. (1993), Fumonisin B1 inhibits sphingosine (sphinganine) N-acyltransferase and de novo sphingolipid biosynthesis in cultured neurons in situ; J. Biol. Chem., 268 27299

FUMONISIN B1Supplier

Nanjing Shizhou Biology Technology Co.,Ltd Gold
Tel
025-85560043 13675144456
Email
sean.lv@synzest.com
Zhejiang Huida Biotech Co., LTD Gold
Tel
0571-89903882 13626641628
Email
jiangnan@huidabiotech.com
Hangzhou Huiyi Biotechnology Co., LTD Gold
Tel
0571-89918262 13357170655
Email
chenlingwei@hizyme.com
Qingdao IniKem BioPharmaTech Co.,Ltd Gold
Tel
0532-58268780
Email
sales@inikem.com
Shanghai Boyle Chemical Co., Ltd.
Tel
021-50182298 021-50180596
Email
sales@boylechem.com